Soylu, H. Et Al. 2023. Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells. Sağlık bilimlerinde değer (Online) , vol.13, no.1 , 6-10.

Soylu, H., AKSU ISTIL, K., Ustunel, I., KARAÇOR, K., & BEYAZÇİÇEK, Ö., (2023). Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells. Sağlık bilimlerinde değer (Online) , vol.13, no.1, 6-10.

Soylu, HAKAN Et Al. "Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells," Sağlık bilimlerinde değer (Online) , vol.13, no.1, 6-10, 2023

Soylu, HAKAN Et Al. "Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells." Sağlık bilimlerinde değer (Online) , vol.13, no.1, pp.6-10, 2023

Soylu, H. Et Al. (2023) . "Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells." Sağlık bilimlerinde değer (Online) , vol.13, no.1, pp.6-10.

@article{article, author={HAKAN SOYLU Et Al. }, title={Abiraterone and Docetaxel Treatments Increase Phospho-PTEN Expression in Metastatic Prostate Cancer Cells}, journal={Sağlık bilimlerinde değer (Online)}, year=2023, pages={6-10} }